Titre : Inhibiteurs de la 5-alpha réductase

Inhibiteurs de la 5-alpha réductase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Interpretation, Statistical
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de la 5-alpha réductase : Questions médicales les plus fréquentes", "headline": "Inhibiteurs de la 5-alpha réductase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibiteurs de la 5-alpha réductase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibiteurs de la 5-alpha réductase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse des stéroïdes", "url": "https://questionsmedicales.fr/mesh/D065088", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse des stéroïdes", "code": { "@type": "MedicalCode", "code": "D065088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.399.450.855" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la 5-alpha réductase", "alternateName": "5-alpha Reductase Inhibitors", "code": { "@type": "MedicalCode", "code": "D058891", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Francesco Del Giudice", "url": "https://questionsmedicales.fr/author/Francesco%20Del%20Giudice", "affiliation": { "@type": "Organization", "name": "Department of Urology, Sapienza University of Rome, Rome, Italy." } }, { "@type": "Person", "name": "James L Mohler", "url": "https://questionsmedicales.fr/author/James%20L%20Mohler", "affiliation": { "@type": "Organization", "name": "Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA." } }, { "@type": "Person", "name": "Thiraphat Saengmearnuparp", "url": "https://questionsmedicales.fr/author/Thiraphat%20Saengmearnuparp", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand." } }, { "@type": "Person", "name": "Bannakij Lojanapiwat", "url": "https://questionsmedicales.fr/author/Bannakij%20Lojanapiwat", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand." } }, { "@type": "Person", "name": "Nipon Chattipakorn", "url": "https://questionsmedicales.fr/author/Nipon%20Chattipakorn", "affiliation": { "@type": "Organization", "name": "Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Online Case-Based Course in Veterinary Radiographic Interpretation Generates Better Short- and Long-Term Learning Outcomes than a Virtual Lecture-Based Course.", "datePublished": "2022-11-29", "url": "https://questionsmedicales.fr/article/36542792", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3138/jvme-2022-0093" } }, { "@type": "ScholarlyArticle", "name": "Classification of SARS-CoV-2 sequences as recombinants via a pre-trained CNN and identification of a mathematical signature relative to recombinant feature at Spike, via interpretability.", "datePublished": "2024-08-26", "url": "https://questionsmedicales.fr/article/39186542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0309391" } }, { "@type": "ScholarlyArticle", "name": "Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature.", "datePublished": "2024-07-29", "url": "https://questionsmedicales.fr/article/39075659", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/his.15287" } }, { "@type": "ScholarlyArticle", "name": "How do people living with obesity who use obesity services perceive healthcare professionals' representation of the disease on social media? An interpretative phenomenological analysis.", "datePublished": "2024-04-15", "url": "https://questionsmedicales.fr/article/38626981", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-081066" } }, { "@type": "ScholarlyArticle", "name": "\"I don't know whether I will be alive or not\" - An interpretative phenomenological analysis of young adult males with Duchenne Muscular Dystrophy making sense of self and life.", "datePublished": "2023-12-30", "url": "https://questionsmedicales.fr/article/38182495", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.dhjo.2023.101578" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Effets physiologiques des médicaments", "item": "https://questionsmedicales.fr/mesh/D045505" }, { "@type": "ListItem", "position": 5, "name": "Hormones, substituts d'hormones et antagonistes d'hormones", "item": "https://questionsmedicales.fr/mesh/D006730" }, { "@type": "ListItem", "position": 6, "name": "Antihormones", "item": "https://questionsmedicales.fr/mesh/D006727" }, { "@type": "ListItem", "position": 7, "name": "Inhibiteurs de la synthèse des stéroïdes", "item": "https://questionsmedicales.fr/mesh/D065088" }, { "@type": "ListItem", "position": 8, "name": "Inhibiteurs de la 5-alpha réductase", "item": "https://questionsmedicales.fr/mesh/D058891" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibiteurs de la 5-alpha réductase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de la 5-alpha réductase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibiteurs de la 5-alpha réductase", "description": "Comment diagnostiquer une hyperplasie bénigne de la prostate ?\nQuels tests sont utilisés pour évaluer la DHT ?\nQuels symptômes indiquent un besoin d'inhibiteurs ?\nComment évaluer l'efficacité des inhibiteurs ?", "url": "https://questionsmedicales.fr/mesh/D058891?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibiteurs de la 5-alpha réductase", "description": "Quels sont les symptômes de l'hyperplasie bénigne de la prostate ?\nLa calvitie est-elle un symptôme lié à la DHT ?\nQuels effets secondaires peuvent survenir ?\nLes inhibiteurs affectent-ils la libido ?", "url": "https://questionsmedicales.fr/mesh/D058891?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibiteurs de la 5-alpha réductase", "description": "Peut-on prévenir l'hyperplasie bénigne de la prostate ?\nY a-t-il des mesures préventives pour la calvitie ?\nLes inhibiteurs peuvent-ils être utilisés préventivement ?\nQuels changements de mode de vie sont recommandés ?", "url": "https://questionsmedicales.fr/mesh/D058891?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibiteurs de la 5-alpha réductase", "description": "Quels médicaments sont des inhibiteurs de la 5-alpha réductase ?\nComment les inhibiteurs agissent-ils ?\nQuelle est la durée du traitement ?\nLes inhibiteurs sont-ils efficaces pour la calvitie ?", "url": "https://questionsmedicales.fr/mesh/D058891?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibiteurs de la 5-alpha réductase", "description": "Quelles complications peuvent survenir avec les inhibiteurs ?\nLes inhibiteurs augmentent-ils le risque de cancer ?\nComment gérer les effets secondaires ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D058891?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibiteurs de la 5-alpha réductase", "description": "Quels sont les facteurs de risque de l'hyperplasie bénigne ?\nLa génétique joue-t-elle un rôle dans la calvitie ?\nLe mode de vie influence-t-il la DHT ?\nL'âge est-il un facteur de risque pour la calvitie ?", "url": "https://questionsmedicales.fr/mesh/D058891?mesh_terms=Data+Interpretation,+Statistical&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une hyperplasie bénigne de la prostate ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique, des tests urinaires et un dosage du PSA aident au diagnostic." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la DHT ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un dosage sanguin de la DHT peut être effectué pour évaluer les niveaux hormonaux." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin d'inhibiteurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes urinaires comme des difficultés à uriner peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des inhibiteurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par l'amélioration des symptômes et la réduction du PSA." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hyperplasie bénigne de la prostate ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des mictions fréquentes, un jet urinaire faible et des douleurs." } }, { "@type": "Question", "name": "La calvitie est-elle un symptôme lié à la DHT ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la DHT est impliquée dans la perte de cheveux androgénétique chez les hommes." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent la dysfonction érectile, la réduction de la libido et la gynécomastie." } }, { "@type": "Question", "name": "Les inhibiteurs affectent-ils la libido ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent éprouver une diminution de la libido en raison des inhibiteurs." } }, { "@type": "Question", "name": "Peut-on prévenir l'hyperplasie bénigne de la prostate ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et un mode de vie actif peuvent aider à réduire le risque." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour la calvitie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des soins capillaires appropriés et des traitements précoces peuvent aider à prévenir la calvitie." } }, { "@type": "Question", "name": "Les inhibiteurs peuvent-ils être utilisés préventivement ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne sont généralement pas utilisés en prévention, mais pour traiter des symptômes existants." } }, { "@type": "Question", "name": "Quels changements de mode de vie sont recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et la gestion du stress sont conseillés." } }, { "@type": "Question", "name": "Quels médicaments sont des inhibiteurs de la 5-alpha réductase ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments comme le finastéride et le dutastéride sont des inhibiteurs connus." } }, { "@type": "Question", "name": "Comment les inhibiteurs agissent-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Ils bloquent la conversion de la testostérone en DHT, réduisant ainsi les symptômes." } }, { "@type": "Question", "name": "Quelle est la durée du traitement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut durer plusieurs mois avant d'observer des résultats significatifs." } }, { "@type": "Question", "name": "Les inhibiteurs sont-ils efficaces pour la calvitie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent ralentir la perte de cheveux et favoriser la repousse chez certains patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les inhibiteurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la dysfonction érectile et des troubles hormonaux peuvent survenir." } }, { "@type": "Question", "name": "Les inhibiteurs augmentent-ils le risque de cancer ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent des résultats contradictoires, mais un suivi médical est recommandé." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un médecin pour ajuster le traitement ou envisager des alternatives est conseillé." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles après l'arrêt du traitement, mais pas toutes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'hyperplasie bénigne ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, l'obésité et des antécédents familiaux augmentent le risque d'hyperplasie bénigne." } }, { "@type": "Question", "name": "La génétique joue-t-elle un rôle dans la calvitie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la génétique est un facteur majeur dans la perte de cheveux androgénétique." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il la DHT ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les niveaux de DHT." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour la calvitie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de calvitie augmente avec l'âge, surtout chez les hommes." } } ] } ] }

Sources (10000 au total)

Classification of SARS-CoV-2 sequences as recombinants via a pre-trained CNN and identification of a mathematical signature relative to recombinant feature at Spike, via interpretability.

The global impact of the SARS-CoV-2 pandemic has underscored the need for a deeper understanding of viral evolution to anticipate new viruses or variants. Genetic recombination is a fundamental mechan...

Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature.

Urothelial carcinoma (UC) demonstrates significant molecular and histologic heterogeneity. The WHO 2022 classification has hinted at adding molecular signatures to the morphologic diagnosis. As morpho... A survey instrument was shared among 98 uropathologists using SurveyMonkey software. Anonymized respondent data were analysed. The response rate was 85%. A majority were in concordance with the profil... In the era of precision medicine, enhanced understanding of molecular heterogeneity of UC will contribute to better therapeutic options, novel biomarker discovery, innovative management protocols, and...

How do people living with obesity who use obesity services perceive healthcare professionals' representation of the disease on social media? An interpretative phenomenological analysis.

The objective of this study was to explore how people living with obesity who use obesity services perceive healthcare professionals' (HCPs) online representation of the disease on social media. By ex... This was a qualitative study using a phenomenological framework. Following in-depth semi-structured interviews, analysis was undertaken to identify superordinate themes relating to how HCPs portray li... Patient advocacy organisation (The Irish Coalition for People Living with Obesity) and three clinical sites offering obesity treatment in Ireland.... 15 adult participants comprising of 12 women and 3 men who use social media and are living with obesity and who use obesity services.... Three key themes of how people living with obesity who use obesity services perceive HCP's online representation of the disease. (1) Negative experiences of HCPs-participants describe encountering wei... HCP's use of social media has a powerful impact on people with obesity who use healthcare and obesity services. Social media is a key tool in obesity awareness and education. We propose the '3E' frame...

"I don't know whether I will be alive or not" - An interpretative phenomenological analysis of young adult males with Duchenne Muscular Dystrophy making sense of self and life.

With ventilatory support, boys with Duchenne Muscular Dystrophy (DMD) now live longer. The emerging adulthood offers unanticipated opportunities for identity exploration. Existing literature has raise... Reveal lived experience and meaning making among men with advanced DMD living outside the western context.... Secondary data, essentially transcripts of semi-structured interviews with five young men with DMD, age ranging from 23 to 37 years, conducted as part of a larger study were analysed iteratively in de... Three themes encapsulated the essence of their lifeworld at this juncture. Each shared poignant stories of having survived adverse circumstances in the past, learning to live with themselves in the cu... Study findings expounded challenges men with advanced DMD grappled that ultimately shaped self-identity. Healthcare professionals could support this group of precarious survivors even better through i...

Non-invasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study.

Perineural invasion (PNI) of intrahepatic cholangiocarcinoma (ICC) is a strong independent risk factor for tumor recurrence and long-term patient survival. However, there is a lack of non-invasive too... This retrospective and prospective study included 243 patients with pathologically diagnosed ICC (training, n=136; external validation, n=81; prospective, n=26, respectively) who underwent preoperativ... Among 243 patients (mean age, 61.2 y ± 11.0 (SD); 152 men and 91 women), 108 (44.4%) were diagnosed as PNI-positive. The radiomics signature was constructed by seven radiomics features, with areas und... We developed and validated a robust combined model incorporating radiomics signature and clinicoradiological features based on machine learning to accurately identify the PNI statuses of ICC, and visu...

A deep learning-based interpretable decision tool for predicting high risk of chemotherapy-induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy.

This study aims to develop a risk prediction model for chemotherapy-induced nausea and vomiting (CINV) in cancer patients receiving highly emetogenic chemotherapy (HEC) and identify the variables that... Data from Tianjin Medical University General Hospital were collected and subjected to stepwise data preprocessing. Deep learning algorithms, including deep forest, and typical machine learning algorit... The deep forest model exhibited good discrimination, outperforming typical machine learning models, with an AUC of 0.850 (95%CI, 0.780-0.919), an F1 score of 0.757, an accuracy of 0.852, a specificity... The deep forest model demonstrated good discrimination in predicting the risk of CINV in cancer patients prescribed HEC. Kidney function, as represented by Ccr, played a crucial role in the model's pr...

'You learn to smile with your eyes', exploring the impact of enhanced personal protective equipment on primary care dental practitioners in the UK: An interpretative phenomenological study.

The aim of the study was to explore how dental practitioners in primary care settings perceive the impact of enhanced personal protective equipment (PPE) upon patient communication and wider clinical ... This study utilized a qualitative approach, rooted in critical realism. An interpretative phenomenological analysis (IPA) methodology was adopted as the study method. In accordance with IPA, in-depth ... Three themes were synthesized (related to communication and clinical practice): (1) Impaired communication and relationship building; (2) Physical impacts and required adjustments when wearing enhance... Dental Practitioners described several barriers to communication as well as physical and mental stressors caused by enhanced-PPE, all of which were perceived to impact upon the quality of care provide...

Access to HIV prevention, treatment, and care services during COVID-19 by men who have sex with men in Zimbabwe, An interpretive phenomenological analysis study.

Key populations are disproportionately affected by the human immunodeficiency virus (HIV) but have less access to HIV prevention and treatment services. The Coronavirus disease-2019 (COVID-19) pandemi... An interpretative phenomenological analysis design was applied to gain some insights regarding the lived experiences of MSM in accessing HIV prevention, treatment, and care services during COVID-19 lo... The findings demonstrated that during the COVID -19 lockdowns in Zimbabwe, MSM faced several barriers as they tried to access HIV services. Some of the barriers included the need for travel authorisat... Limited access to healthcare services by MSM due to COVID-19 lockdown may negatively affect the viral suppression and fuel the spread of HIV, which may reverse the gains toward the control of HIV epid...